©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 109859
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109859
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109859
Figure 4 Effects of vascular endothelial growth factor on angiogenesis.
A: Wound healing assay demonstrated that conditioned medium (CM) promoted human umbilical vein endothelial cell migration, while a vascular endothelial growth factor-neutralizing antibody attenuated the promigratory effects of CM; B: Statistical bar chart of the cell migration rate at 6 and 24 hours after scratching; C: A tube formation assay showed that CM promoted angiogenesis, while antibody attenuated the proangiogenic effects of CM. The data are presented as mean ± SD. Scale bar, 200 μm. HUVECs: Human umbilical vein endothelial cells; Ab: Antibody; CM: Conditioned medium. aP < 0.01 vs human umbilical vein endothelial cells, bP < 0.0001 vs human umbilical vein endothelial cells, cP < 0.01 vs human umbilical vein endothelial cells + conditioned medium, and dP < 0.001 vs human umbilical vein endothelial cells + conditioned medium.
- Citation: Cao J, Liu ZC, An WQ, Zhang S, Zhang X, Li LJ, Ji HL, Long X, Yang YM. Optimizing adipose-derived stem cell therapy for diabetic foot ulcers. World J Diabetes 2025; 16(11): 109859
- URL: https://www.wjgnet.com/1948-9358/full/v16/i11/109859.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i11.109859